Author(s):
Proença, Paula 
; Teixeira, Helena ; Pinheiro, João ; Marques, Estela P. ; Vieira, Duarte Nuno
Date: 2004
Persistent ID: http://hdl.handle.net/10316/4782
Origin: Estudo Geral - Universidade de Coimbra
Subject(s): Forensic intoxication; Clobazam; HPLC/DAD/MSD
Description
Clobazam (Castillium®, Urbanil®), a benzodiazepine often used as an anxiolytic and in the treatment of epilepsy, is considered a relatively safe drug. The authors present a fatal case with a 49-year-old female, found dead at home. She had been undergoing psychiatric treatment and was a chronic alcoholic. The autopsy findings were unremarkable, except for multivisceral congestion, steatosis and a small piece of a plastic blister pack in the stomach. Bronchopneumonia, bronchitis and bronchiolitis were also diagnosed. Anhigh-performance liquid chromatography (HPLC)/diode array detector (DAD)/mass spectrometry detection (MSD) with electrospray method was developed in order to detect, confirm and quantify clobazam in the post-mortem samples. In the chromatographic separation, a reversed-phase column C18 (2.1×150 mm, 3.5 [mu]m) was used with a mobile phase of methanol and water, at a 0.25 ml/min flow rate. Carbonate buffer (pH 10.5) and 20 [mu]l of prazepam (100 [mu]g/ml) as internal standard were added to the samples. A simple and reliable liquid-liquid extraction method for the determination of clobazam in post-mortem samples was described. Calibration curves for clobazam were performed in blood, achieving linearity between 0.01 and 10 [mu]g/ml and a detection limit of 1.0 ng/ml. The clobazam concentration found in post-mortem blood was 3.9 [mu]g/ml, higher than the reported therapeutic concentration (0.1-0.4 [mu]g/ml). The simultaneous acquisition by photodiode array detection and mass spectrometry detection results allowed benzodiazepines to be identified with sufficient certainty. http://www.sciencedirect.com/science/article/B6T6W-4CGMBTV-4/1/f7a0b1e679ea4d8559b70daffa452c63
